United States Pharmaceuticals

Opus Genetics Inc (IRD)

Track

Track

Opus Genetics experienced significant insider selling over the past ninety days, with executives offloading shares totaling approximately 86,585 dollars. These transactions occurred alongside a stable stock performance. Following the most recent results financiers, leadership members including the CEO and CFO executed multiple divestments, reflecting a trend of net selling activity among key corporate personnel.
Ticker: IRD Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Opus Genetics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.7
YERXA BENJAMIN R President Executive Director
Transaction date
Sale
Price
415.16
Quantity 81,457 -34.0%
Value US$1,833,861
3.1
SCHACHLE JOSEPH K Chief Operating Officer Officer
Transaction date
Sale
Price
179.03
Quantity 31,648 -32.0%
Value US$4,012,390
3.1
Gagnon Robert E. Chief Financial Officer Officer
Transaction date
Sale
Price
11.79
Quantity 86,551 -35.6%
Value US$2,334,639
3.5
Magrath George Chief Executive Officer Executive Director
Transaction date
Sale
Price
2.95
Quantity 9,475 -0.5%
Value US$27,926
3.1
Gagnon Robert E. Officer Officer
Transaction date
Proposed sale
Price
3.05
Quantity 7,783
Value US$23,738
3.5
Magrath George Officer Officer
Transaction date
Proposed sale
Price
3.05
Quantity 9,475
Value US$28,899
3.1
SCHACHLE JOSEPH K Officer Officer
Transaction date
Proposed sale
Price
2.94
Quantity 4,644
Value US$13,653
3.7
YERXA BENJAMIN R Officer Officer
Transaction date
Proposed sale
Price
2.97
Quantity 7,429
Value US$22,064
3.7
YERXA BENJAMIN R President Executive Director
Transaction date
Sale
Price
5.24
Quantity 7,470 -1.0%
Value US$39,121
3.1
Gagnon Robert E. Chief Financial Officer Officer
Transaction date
Sale
Price
5.18
Quantity 7,842 -1.3%
Value US$40,658
3.5
Magrath George Chief Executive Officer Executive Director
Transaction date
Sale
Price
5.22
Quantity 9,511 -0.5%
Value US$49,647
3.2
Zaremba Rabourn Amy Head of Fin. Quality Assurance Officer
Transaction date
Sale
Price
5.20
Quantity 1,641 -0.9%
Value US$8,540
3.1
SCHACHLE JOSEPH K Chief Operating Officer Officer
Transaction date
Sale
Price
5.22
Quantity 4,697 -1.6%
Value US$24,519
3.3
Jayagopal Ashwath Chief Scientific & Dev. Ofc. Officer
Transaction date
Sale
Price
5.19
Quantity 7,542 -1.5%
Value US$39,156
3.1
SCHACHLE JOSEPH K Officer Officer
Transaction date
Proposed sale
Price
5.22
Quantity 4,697
Value US$24,519
3.7
YERXA BENJAMIN R Officer Officer
Transaction date
Proposed sale
Price
5.24
Quantity 7,470
Value US$39,121
3.5
Magrath George Officer Officer
Transaction date
Proposed sale
Price
13.39
Quantity 9,511
Value US$127,327
3.1
Gagnon Robert E. Officer Officer
Transaction date
Proposed sale
Price
5.18
Quantity 7,842
Value US$40,658
3.3
Jayagopal Ashwath Officer Officer
Transaction date
Proposed sale
Price
5.19
Quantity 7,542
Value US$39,156
3.2
Zaremba Rabourn Amy Head of Fin. Quality Assurance Officer
Transaction date
Sale
Price
5.25
Quantity 2,816 -1.5%
Value US$14,770
3.1
SCHACHLE JOSEPH K Chief Operating Officer Officer
Transaction date
Sale
Price
5.25
Quantity 3,719 -1.2%
Value US$19,525
3.5
Magrath George Chief Executive Officer Executive Director
Transaction date
Sale
Price
5.21
Quantity 24,438 -1.4%
Value US$127,327
3.3
Jayagopal Ashwath Chief Scientific & Dev. Ofc. Officer
Transaction date
Sale
Price
5.12
Quantity 3,719 -0.7%
Value US$19,046
3.5
Magrath George Officer Officer
Transaction date
Proposed sale
Price
5.21
Quantity 24,438
Value US$127,327
3.4
Gallagher Cam Non-Executive Director
Transaction date
Purchase
Price
1.97
Quantity 83,000 +inf%
Value US$163,419
3.4
Gallagher Cam Non-Executive Director
Transaction date
Purchase
Price
1.98
Quantity 81,000 +4.5%
Value US$160,275
3.5
Magrath George Chief Executive Officer Officer
Transaction date
Purchase
Price
0.98
Quantity 100,000 +20.0%
Value US$97,600
3.7
YERXA BENJAMIN R President Executive Director
Transaction date
Purchase
Price
0.98
Quantity 10,000 +3.0%
Value US$9,834
3.5
Magrath George Chief Executive Officer Officer
Transaction date
Purchase
Price
1.02
Quantity 9,706 +2.0%
Value US$9,943
3.5
Magrath George Chief Executive Officer Officer
Transaction date
Purchase
Price
1.01
Quantity 90,294 +23.0%
Value US$91,215
3.3
Jayagopal Ashwath Chief Scientific & Dev. Ofc. Officer
Transaction date
Purchase
Price
1.77
Quantity 3,500 +4.7%
Value US$6,178
3.5
Magrath George Chief Executive Officer Officer
Transaction date
Purchase
Price
1.75
Quantity 5,000 +1.2%
Value US$8,772
3.5
Magrath George Chief Executive Officer Officer
Transaction date
Purchase
Price
1.75
Quantity 5,000 +1.2%
Value US$8,772
0.7
Jhaveri Nirav S. Chief Financial Officer Officer
Transaction date
Purchase
Price
2.10
Quantity 10,000 +7.1%
Value US$21,000
3.1
SCHACHLE JOSEPH K Chief Operating Officer Officer
Transaction date
Purchase
Price
2.05
Quantity 2,000 +inf%
Value US$4,100
3.5
Magrath George Chief Executive Officer Officer
Transaction date
Purchase
Price
1.96
Quantity 25,000 +6.2%
Value US$49,050
3.4
MANUSO JAMES S J Non-Executive Director
Transaction date
Purchase
Price
1.99
Quantity 5,000 +30.2%
Value US$9,950
2.8
Sooch Mina President and CEO Executive Director
Transaction date
Purchase
Price
2.02
Quantity 12,500 +3.0%
Value US$25,300
2.8
Sooch Mina President and CEO Executive Director
Transaction date
Purchase
Price
2.07
Quantity 12,500 +3.1%
Value US$25,879
1.4
Pepose Jay Non-Executive Director
Transaction date
Purchase
Price
3.65
Quantity 8,250 +56.0%
Value US$30,112
3.4
MANUSO JAMES S J Non-Executive Director
Transaction date
Purchase
Price
3.50
Quantity 2,000 +13.7%
Value US$7,000
3.4
Gallagher Cam Non-Executive Director
Transaction date
Purchase
Price
0.00
Quantity 8,865
Value US$0
3.4
MANUSO JAMES S J Non-Executive Director
Transaction date
Purchase
Price
0.00
Quantity 4,434
Value US$0
2.8
Sooch Mina President and CEO Executive Director
Transaction date
Purchase
Price
0.00
Quantity 11,524
Value US$0
Rodgers Richard J Non-Executive Director
Transaction date
Purchase
Price
0.00
Quantity 17,730
Value US$0
Ainsworth Sean Non-Executive Director
Transaction date
Purchase
Price
0.00
Quantity 8,865
Value US$0
MEYER ALAN R Non-Executive Director
Transaction date
Purchase
Price
0.00
Quantity 1,771
Value US$0
0.6
Beever Charles
Transaction date
Purchase
Price
0.64
Quantity 10,000 +1000.0%
Value US$6,380
0.6
Nolan Lisa Chief Business Officer
Transaction date
Purchase
Price
0.65
Quantity 20,000 +1230.8%
Value US$12,960
0.6
Price Ben Gil
Transaction date
Purchase
Price
0.61
Quantity 15,000 +inf%
Value US$9,141
1.2
Swirsky Douglas J President and CEO
Transaction date
Purchase
Price
0.63
Quantity 50,000 +inf%
Value US$31,720
Ahn Chang Ho
Transaction date
Planned sale
Price
0.70
Quantity 250,000 -4.0%
Value US$175,375
Jeong Tae Heum Chief Financial Officer Officer
Transaction date
Planned sale
Price
0.91
Quantity 49,800 -9.0%
Value US$45,492
Ahn Chang Ho Non-Executive Director
Transaction date
Planned sale
Price
0.91
Quantity 48,444 -0.8%
Value US$44,263
Jeong Tae Heum Chief Financial Officer Officer
Transaction date
Planned sale
Price
0.92
Quantity 188,690 -27.2%
Value US$172,708
Ahn Chang Ho Non-Executive Director
Transaction date
Planned sale
Price
0.92
Quantity 186,212 -3.0%
Value US$170,477
Jeong Tae Heum Chief Financial Officer Officer
Transaction date
Planned sale
Price
0.90
Quantity 78,782 -13.5%
Value US$70,935
Ahn Chang Ho Non-Executive Director
Transaction date
Planned sale
Price
0.90
Quantity 80,000 -1.3%
Value US$72,032
Ahn Chang Ho Non-Executive Director
Transaction date
Sale
Price
0.99
Quantity 136,193 -2.0%
Value US$134,436
Jeong Tae Heum Chief Financial Officer Officer
Transaction date
Sale
Price
0.46
Quantity 71,139 -12.3%
Value US$32,475
Kivel Richard Non-Executive Director
Transaction date
Purchase
Price
1.04
Quantity 2,500 +inf%
Value US$2,600
Brandt Peter C. Non-Executive Director
Transaction date
Purchase
Price
1.23
Quantity 5,000 +3.4%
Value US$6,150
Brandt Peter C. Non-Executive Director
Transaction date
Purchase
Price
1.22
Quantity 13,300 +10.1%
Value US$16,213
Brandt Peter C. Non-Executive Director
Transaction date
Purchase
Price
1.22
Quantity 55,100 +71.9%
Value US$67,222
Brandt Peter C. Non-Executive Director
Transaction date
Purchase
Price
1.21
Quantity 6,600 +9.4%
Value US$7,986
Brandt Peter C. Non-Executive Director
Transaction date
Purchase
Price
1.08
Quantity 15,000 +27.3%
Value US$16,185
Brandt Peter C. Non-Executive Director
Transaction date
Purchase
Price
1.10
Quantity 2,500 +4.8%
Value US$2,748
Brandt Peter C. Non-Executive Director
Transaction date
Purchase
Price
1.09
Quantity 5,912 +12.7%
Value US$6,444
Brandt Peter C. Non-Executive Director
Transaction date
Purchase
Price
1.10
Quantity 13,800 +42.1%
Value US$15,180
Brandt Peter C. Non-Executive Director
Transaction date
Purchase
Price
1.12
Quantity 7,200 +28.1%
Value US$8,064
Brandt Peter C. Non-Executive Director
Transaction date
Purchase
Price
1.13
Quantity 588 +2.4%
Value US$664
Brandt Peter C. Non-Executive Director
Transaction date
Purchase
Price
1.04
Quantity 5,000 +25.0%
Value US$5,200
Brandt Peter C. Non-Executive Director
Transaction date
Purchase
Price
0.95
Quantity 300 +1.5%
Value US$284
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-27 2026-07-23 S Sale
3.7
YERXA BENJAMIN R

President

Executive Director
81,457 -34.0%
415.16
US$1,833,861 		81,457 -34.0% 415.16 US$1,833,861
2026-07-27 2026-07-23 S Sale
3.1
SCHACHLE JOSEPH K

Chief Operating Officer

Officer
31,648 -32.0%
179.03
US$4,012,390 		31,648 -32.0% 179.03 US$4,012,390
2026-07-27 2026-07-23 S Sale
3.1
Gagnon Robert E.

Chief Financial Officer

Officer
86,551 -35.6%
11.79
US$2,334,639 		86,551 -35.6% 11.79 US$2,334,639
2026-07-27 2026-07-23 S Sale
3.5
Magrath George

Chief Executive Officer

Executive Director
9,475 -0.5%
2.95
US$27,926 		9,475 -0.5% 2.95 US$27,926
2026-07-23 2026-07-23 PrS Proposed sale
3.1
Gagnon Robert E.

Officer

Officer
7,783
3.05
US$23,738 		7,783 3.05 US$23,738
2026-07-23 2026-07-23 PrS Proposed sale
3.5
Magrath George

Officer

Officer
9,475
3.05
US$28,899 		9,475 3.05 US$28,899
2026-07-23 2026-07-23 PrS Proposed sale
3.1
SCHACHLE JOSEPH K

Officer

Officer
4,644
2.94
US$13,653 		4,644 2.94 US$13,653
2026-07-23 2026-07-23 PrS Proposed sale
3.7
YERXA BENJAMIN R

Officer

Officer
7,429
2.97
US$22,064 		7,429 2.97 US$22,064
2026-05-20 2026-05-18 S Sale
Foundation Fighting Blindness Retinal Degeneration Fund

See Remarks

Non-Executive Director
1,700,000 -31.0%
4.35
US$7,395,000 		1,700,000 -31.0% 4.35 US$7,395,000
2026-04-27 2026-04-23 S Sale
3.7
YERXA BENJAMIN R

President

Executive Director
7,470 -1.0%
5.24
US$39,121 		7,470 -1.0% 5.24 US$39,121
2026-04-27 2026-04-23 S Sale
3.1
Gagnon Robert E.

Chief Financial Officer

Officer
7,842 -1.3%
5.18
US$40,658 		7,842 -1.3% 5.18 US$40,658
2026-04-27 2026-04-23 S Sale
3.5
Magrath George

Chief Executive Officer

Executive Director
9,511 -0.5%
5.22
US$49,647 		9,511 -0.5% 5.22 US$49,647
2026-04-27 2026-04-23 S Sale
3.2
Zaremba Rabourn Amy

Head of Fin. Quality Assurance

Officer
1,641 -0.9%
5.20
US$8,540 		1,641 -0.9% 5.20 US$8,540
2026-04-27 2026-04-23 S Sale
3.1
SCHACHLE JOSEPH K

Chief Operating Officer

Officer
4,697 -1.6%
5.22
US$24,519 		4,697 -1.6% 5.22 US$24,519
2026-04-27 2026-04-23 S Sale
3.3
Jayagopal Ashwath

Chief Scientific & Dev. Ofc.

Officer
7,542 -1.5%
5.19
US$39,156 		7,542 -1.5% 5.19 US$39,156
2026-04-23 2026-04-23 PrS Proposed sale
3.1
SCHACHLE JOSEPH K

Officer

Officer
4,697
5.22
US$24,519 		4,697 5.22 US$24,519
2026-04-23 2026-04-23 PrS Proposed sale
3.7
YERXA BENJAMIN R

Officer

Officer
7,470
5.24
US$39,121 		7,470 5.24 US$39,121
2026-04-23 2026-04-23 PrS Proposed sale
3.5
Magrath George

Officer

Officer
9,511
13.39
US$127,327 		9,511 13.39 US$127,327
2026-04-23 2026-04-23 PrS Proposed sale
3.1
Gagnon Robert E.

Officer

Officer
7,842
5.18
US$40,658 		7,842 5.18 US$40,658
2026-04-23 2026-04-23 PrS Proposed sale
3.3
Jayagopal Ashwath

Officer

Officer
7,542
5.19
US$39,156 		7,542 5.19 US$39,156
2026-03-18 2026-03-16 S Sale
3.2
Zaremba Rabourn Amy

Head of Fin. Quality Assurance

Officer
2,816 -1.5%
5.25
US$14,770 		2,816 -1.5% 5.25 US$14,770
2026-03-18 2026-03-16 S Sale
3.1
SCHACHLE JOSEPH K

Chief Operating Officer

Officer
3,719 -1.2%
5.25
US$19,525 		3,719 -1.2% 5.25 US$19,525
2026-03-18 2026-03-16 S Sale
3.5
Magrath George

Chief Executive Officer

Executive Director
24,438 -1.4%
5.21
US$127,327 		24,438 -1.4% 5.21 US$127,327
2026-03-18 2026-03-16 S Sale
3.3
Jayagopal Ashwath

Chief Scientific & Dev. Ofc.

Officer
3,719 -0.7%
5.12
US$19,046 		3,719 -0.7% 5.12 US$19,046
2026-03-16 2026-03-16 PrS Proposed sale
3.5
Magrath George

Officer

Officer
24,438
5.21
US$127,327 		24,438 5.21 US$127,327
2025-12-31 2025-12-29 B Purchase
3.4
Gallagher Cam
Non-Executive Director
83,000 +inf%
1.97
US$163,419 		83,000 +inf% 1.97 US$163,419
2025-12-31 2025-12-29 B Purchase
3.4
Gallagher Cam
Non-Executive Director
81,000 +4.5%
1.98
US$160,275 		81,000 +4.5% 1.98 US$160,275
2025-12-11 2025-12-09 S Sale
Foundation Fighting Blindness Retinal Degeneration Fund

See Remarks

Non-Executive Director
4,000,000 -42.1%
2.15
US$8,600,000 		4,000,000 -42.1% 2.15 US$8,600,000
2024-12-30 2024-12-26 B Purchase
3.5
Magrath George

Chief Executive Officer

Officer
100,000 +20.0%
0.98
US$97,600 		100,000 +20.0% 0.98 US$97,600
2024-11-25 2024-11-21 B Purchase
3.7
YERXA BENJAMIN R

President

Executive Director
10,000 +3.0%
0.98
US$9,834 		10,000 +3.0% 0.98 US$9,834
2024-11-19 2024-11-18 B Purchase
3.5
Magrath George

Chief Executive Officer

Officer
9,706 +2.0%
1.02
US$9,943 		9,706 +2.0% 1.02 US$9,943
2024-11-19 2024-11-15 B Purchase
3.5
Magrath George

Chief Executive Officer

Officer
90,294 +23.0%
1.01
US$91,215 		90,294 +23.0% 1.01 US$91,215
2024-05-24 2024-05-22 B Purchase
3.3
Jayagopal Ashwath

Chief Scientific & Dev. Ofc.

Officer
3,500 +4.7%
1.77
US$6,178 		3,500 +4.7% 1.77 US$6,178
2024-05-21 2024-05-17 B Purchase
3.5
Magrath George

Chief Executive Officer

Officer
5,000 +1.2%
1.75
US$8,772 		5,000 +1.2% 1.75 US$8,772
2024-05-21 2024-05-17 B Purchase
3.5
Magrath George

Chief Executive Officer

Officer
5,000 +1.2%
1.75
US$8,772 		5,000 +1.2% 1.75 US$8,772
2024-03-25 2024-03-21 B Purchase
0.7
Jhaveri Nirav S.

Chief Financial Officer

Officer
10,000 +7.1%
2.10
US$21,000 		10,000 +7.1% 2.10 US$21,000
2024-03-25 2024-03-21 B Purchase
3.1
SCHACHLE JOSEPH K

Chief Operating Officer

Officer
2,000 +inf%
2.05
US$4,100 		2,000 +inf% 2.05 US$4,100
2024-03-20 2024-03-18 B Purchase
3.5
Magrath George

Chief Executive Officer

Officer
25,000 +6.2%
1.96
US$49,050 		25,000 +6.2% 1.96 US$49,050
2022-05-24 2022-05-20 B Purchase
3.4
MANUSO JAMES S J
Non-Executive Director
5,000 +30.2%
1.99
US$9,950 		5,000 +30.2% 1.99 US$9,950
2022-05-23 2022-05-20 B Purchase
2.8
Sooch Mina

President and CEO

Executive Director
12,500 +3.0%
2.02
US$25,300 		12,500 +3.0% 2.02 US$25,300
2022-05-23 2022-05-19 B Purchase
2.8
Sooch Mina

President and CEO

Executive Director
12,500 +3.1%
2.07
US$25,879 		12,500 +3.1% 2.07 US$25,879
2021-12-14 2021-12-13 B Purchase
1.4
Pepose Jay
Non-Executive Director
8,250 +56.0%
3.65
US$30,112 		8,250 +56.0% 3.65 US$30,112
2021-11-22 2021-11-18 B Purchase
3.4
MANUSO JAMES S J
Non-Executive Director
2,000 +13.7%
3.50
US$7,000 		2,000 +13.7% 3.50 US$7,000
2020-11-25 2020-11-19 B Purchase
3.4
Gallagher Cam
Non-Executive Director
8,865
0.00
US$0 		8,865 0.00 US$0
2020-11-25 2020-11-19 B Purchase
3.4
MANUSO JAMES S J
Non-Executive Director
4,434
0.00
US$0 		4,434 0.00 US$0
2020-11-25 2020-11-19 B Purchase
2.8
Sooch Mina

President and CEO

Executive Director
11,524
0.00
US$0 		11,524 0.00 US$0
2020-11-25 2020-11-19 B Purchase
Rodgers Richard J
Non-Executive Director
17,730
0.00
US$0 		17,730 0.00 US$0
2020-11-25 2020-11-19 B Purchase
Ainsworth Sean
Non-Executive Director
8,865
0.00
US$0 		8,865 0.00 US$0
2020-11-25 2020-11-19 B Purchase
MEYER ALAN R
Non-Executive Director
1,771
0.00
US$0 		1,771 0.00 US$0
2019-02-04 2019-01-31 B Purchase
0.6
Beever Charles
10,000 +1000.0%
0.64
US$6,380 		10,000 +1000.0% 0.64 US$6,380
2019-01-31 2019-01-30 B Purchase
0.6
Nolan Lisa

Chief Business Officer
20,000 +1230.8%
0.65
US$12,960 		20,000 +1230.8% 0.65 US$12,960
2019-01-31 2019-01-29 B Purchase
0.6
Price Ben Gil
15,000 +inf%
0.61
US$9,141 		15,000 +inf% 0.61 US$9,141
2019-01-30 2019-01-29 B Purchase
1.2
Swirsky Douglas J

President and CEO
50,000 +inf%
0.63
US$31,720 		50,000 +inf% 0.63 US$31,720
2017-04-12 2017-04-10 PlS Planned sale Ahn Chang Ho
250,000 -4.0%
0.70
US$175,375 		250,000 -4.0% 0.70 US$175,375
2015-01-12 2015-01-12 PlS Planned sale Jeong Tae Heum

Chief Financial Officer

Officer
49,800 -9.0%
0.91
US$45,492 		49,800 -9.0% 0.91 US$45,492
2015-01-12 2015-01-12 PlS Planned sale Ahn Chang Ho Non-Executive Director
48,444 -0.8%
0.91
US$44,263 		48,444 -0.8% 0.91 US$44,263
2015-01-12 2015-01-09 PlS Planned sale Jeong Tae Heum

Chief Financial Officer

Officer
188,690 -27.2%
0.92
US$172,708 		188,690 -27.2% 0.92 US$172,708
2015-01-12 2015-01-09 PlS Planned sale Ahn Chang Ho Non-Executive Director
186,212 -3.0%
0.92
US$170,477 		186,212 -3.0% 0.92 US$170,477
2015-01-12 2015-01-08 PlS Planned sale Jeong Tae Heum

Chief Financial Officer

Officer
78,782 -13.5%
0.90
US$70,935 		78,782 -13.5% 0.90 US$70,935
2015-01-12 2015-01-08 PlS Planned sale Ahn Chang Ho Non-Executive Director
80,000 -1.3%
0.90
US$72,032 		80,000 -1.3% 0.90 US$72,032
2014-06-16 2014-06-12 S Sale Ahn Chang Ho Non-Executive Director
136,193 -2.0%
0.99
US$134,436 		136,193 -2.0% 0.99 US$134,436
2013-09-11 2013-09-09 S Sale Jeong Tae Heum

Chief Financial Officer

Officer
71,139 -12.3%
0.46
US$32,475 		71,139 -12.3% 0.46 US$32,475
2011-10-21 2011-10-03 B Purchase Kivel Richard Non-Executive Director
2,500 +inf%
1.04
US$2,600 		2,500 +inf% 1.04 US$2,600
2011-09-12 2011-09-09 B Purchase Brandt Peter C. Non-Executive Director
5,000 +3.4%
1.23
US$6,150 		5,000 +3.4% 1.23 US$6,150
2011-09-12 2011-09-09 B Purchase Brandt Peter C. Non-Executive Director
13,300 +10.1%
1.22
US$16,213 		13,300 +10.1% 1.22 US$16,213
2011-09-12 2011-09-09 B Purchase Brandt Peter C. Non-Executive Director
55,100 +71.9%
1.22
US$67,222 		55,100 +71.9% 1.22 US$67,222
2011-09-12 2011-09-09 B Purchase Brandt Peter C. Non-Executive Director
6,600 +9.4%
1.21
US$7,986 		6,600 +9.4% 1.21 US$7,986
2011-09-12 2011-09-08 B Purchase Brandt Peter C. Non-Executive Director
15,000 +27.3%
1.08
US$16,185 		15,000 +27.3% 1.08 US$16,185
2011-09-12 2011-09-08 B Purchase Brandt Peter C. Non-Executive Director
2,500 +4.8%
1.10
US$2,748 		2,500 +4.8% 1.10 US$2,748
2011-09-12 2011-09-08 B Purchase Brandt Peter C. Non-Executive Director
5,912 +12.7%
1.09
US$6,444 		5,912 +12.7% 1.09 US$6,444
2011-09-12 2011-09-08 B Purchase Brandt Peter C. Non-Executive Director
13,800 +42.1%
1.10
US$15,180 		13,800 +42.1% 1.10 US$15,180
2011-09-12 2011-09-08 B Purchase Brandt Peter C. Non-Executive Director
7,200 +28.1%
1.12
US$8,064 		7,200 +28.1% 1.12 US$8,064
2011-09-12 2011-09-08 B Purchase Brandt Peter C. Non-Executive Director
588 +2.4%
1.13
US$664 		588 +2.4% 1.13 US$664
2011-09-08 2011-09-07 B Purchase Brandt Peter C. Non-Executive Director
5,000 +25.0%
1.04
US$5,200 		5,000 +25.0% 1.04 US$5,200
2011-09-08 2011-09-06 B Purchase Brandt Peter C. Non-Executive Director
300 +1.5%
0.95
US$284 		300 +1.5% 0.95 US$284
Explore more

More insider trading research around Opus Genetics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America